Advertisement

Topics

The Dallas 100 Entrepreneur Awards Places Thermi At The Top For The Second Year In A Row

11:00 EST 1 Dec 2016 | PR Newswire

DALLAS, Dec. 1, 2016 /PRNewswire/ -- The Southern Methodist University's Caruth Institute for Entrepreneurship has recognized ThermiGen,LLC (dba, Thermi), as the tenth fastest growing Dallas-based company in the 26th annual Dallas 100 Entrepreneur Awards. This recognition salutes the company, which, in recent years has become the world-leading manufacturer of temperature controlled radiofrequency medical devices for the aesthetic marketplace.

"This is a huge accomplishment and great honor for Thermi to be recognized for the second year in a row. We recognize that the company has been greatly blessed, and we are the beneficiaries of countless positive effects on our business, many of which were beyond our control. Actually, in this amazing journey we have experienced rapid growth and success while receiving needed financial and commercial resources 'Just-in-Time.' Thermi® is pleased and honored to have their continued success celebrated among other thriving businesses within the Dallas area," said CEO and Co-Founder Paul Herchman. President and Co-Founder Kevin O'Brien stated, "The success of Thermi has been accomplished through the unrelenting efforts and talent of our loyal and driven employees, many key physician investors and happy customers, and we are greatly appreciative of their contributions."

The Dallas 100™ acknowledges and honors the area's top 100 entrepreneurial success stories. Thermi, a worldwide manufacturer and distributor of temperature-controlled radiofrequency devices, exemplifies one of the many innovative companies being honored, due to its innovative team, physician support and unique system.

Mike McDonald, Thermi COO also said, "This award on the heels of the acquisition of Thermi by Barcelona-based Almirall for $82 million in February of this year makes 2016 a year of monumental accomplishments for the Thermi family. The Thermi Team has embodied the awards' required entrepreneurial spirit by having achieved high levels of productivity and efficiency over the past three years."

Thermi, an Almirall Company, is a leading global manufacturer of temperature controlled radiofrequency technology. The company's flagship product is ThermiRF®, a platform technology that uses temperature as a clinical endpoint for various minimally invasive and non-invasive applications (ThermiTight®, ThermiRase®, ThermiSmooth®, ThermiVa®). Thermi also offers the Thermi250 device as the newest innovative RF technology for non-invasive aesthetic applications. 

The Dallas 100 Entrepreneur Awards considers independent, privately held corporations (excluding non-profit organizations) that are headquartered in the Dallas Metroplex area. Applicants must have proven sales of more $500,000.00 but less than $75,000,000.00 per fiscal year, with an overall steady business growth over the past three years

For more information please visit: http://www.thermi.com/

EDITOR'S NOTE: For more information about THERMI and to arrange to speak with a company spokesperson, please contact Nancy Trent or Pamela Wadler at 212-966-0024 or info(at)trentandcompany(dot)com.

Photo - http://photos.prnewswire.com/prnh/20161201/444878

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-dallas-100-entrepreneur-awards-places-thermi-at-the-top-for-the-second-year-in-a-row-300371729.html

SOURCE Thermi

NEXT ARTICLE

More From BioPortfolio on "The Dallas 100 Entrepreneur Awards Places Thermi At The Top For The Second Year In A Row"

Quick Search
Advertisement
 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...